The Use of Adenosine in the Assessment of Stable Coronary Heart Disease

World Health Organisation. Types of cardiovascular disease. https://www.who.int/cardiovascular_diseases/resources/atlas/en/ (accessed 27/07/19).

British Cardiovascular Intervention Society. BCIS Audit Report for 2016. https://www.bcis.org.uk/resources/audit-results/ (accessed 27/07/19).

Fischer JJ , Samady H , McPherson JA . Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity. Am J Cardiol 2002; 90: 210–5.

Windecker S , Kolh P , Alfonso F . 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541–619.

Montalescot G , Sechtem U , Achenbach S . 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949–3003.

Pijls NH , De Bruyne B , Peels K . Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334: 1703–8.

Watkins S , McGeoch R , Lyne J . Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation 2009; 120: 2207–13.

Corcoran D , Young R , Adlam D . Coronary microvascular dysfunction in patients with stable coronary artery disease: the CE-MARC 2 coronary physiology sub-study. Int J Cardiol 2018; 266: 7–14.

Mundhenke M , Schwartzkopff B , Strauer BE . Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Archiv 1997; 431: 265–73.

Campbell DJ , Somaratne JB , Jenkins AJ . Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease. Hypertension 2011; 57: 186–92.

Fearon WF , Balsam LB , Farouque HM . Novel index for invasively assessing the coronary microcirculation. Circulation 2003; 107: 3129–32.

Fearon WF , Low AF , Yong AS . Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation 2013; 127: 2436–41.

Patel MR , Dai D , Hernandez AF . Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J 2014; 167: 846–52.e2.

Chest Pain of Recent Onset: Assessment and Diagnosis (CG95). London: National Institute for Health and Care Excellence; 2010 (Updated 2016).

Brown KA . Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 1991; 83: 363–81.

Greenwood JP , Ripley DP , Berry C . Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE Guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA 2016; 316: 1051–60.

Nagel E , Greenwood JP , McCann GP . Magnetic resonance perfusion or fractional flow reserve in coronary disease. N Engl J Med 2019; 380: 2418–28.

Sheth S , Brito R , Mukherjea D . Adenosine receptors: expression, function and regulation. Int J Mol Sci 2014; 15: 2024–52.

Morrow A , Ford TJ , Brogan R . Incidence of acute bronchospasm during systemic adenosine administration for coronary angiography. J R Coll Physicians Edinb 2019; 49: 204–6.

Fairbairn TA , Nieman K , Akasaka T . Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry. Eur Heart J 2018; 39: 3701–11.